Menu
BREAKING THROUGH TO FUNDING CANCER RESEARCH CLINICAL TRIALS
Gateway for Cancer Research accelerates practice-changing discoveries in cancer care by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.
For Researchers
Explore Gateway’s cutting-edge cancer research program
Gateway Impact
Learn more about Gateway for Cancer Research and our critical mission
For Supporters
Donate to cancer research today and help advance lifesaving cancer research
GATEWAY FOR CANCER RESEARCH STORIES
Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.
Gateway’s Impact
10,000+ patients have been impacted by Gateway for Cancer Research funded clinical trials to date.
READ MORE
Patient Profile: Curt
Curt enrolled in a Gateway-funded cancer research trial to treat his kidney cancer. See what he and his doctor had to say about his experience in this trial.
Watch Curt’s StoryWhy Give to Gateway
100% of all donations directly fund early phase clinical cancer research.
DONATE NOW
Get your Copy of GLOW Today!
Support Gateway for Cancer Research and get your free GLOW book today.
Find out how here“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”
- Beth, lymphoma patient in a Gateway-funded trial
Gateway News
Gateway-funded pancreas cancer clinical trail at OSU expanding with drug manufacturer support.
Read MoreDid You Know?
227 clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.
View Our Clinical Trials
Extraordinary Times Call for Extraordinary Measures
COVID-19 significantly disrupted patient access to clinical trials—research that can make a world of difference for those facing cancer. In response to this long-term trend, Gateway launched an innovative new funding program to support “decentralized” clinical studies that bring trials to the doorsteps of cancer patients by leveraging technology and at-home care.
Extraordinary Measures, an urgent new fundraising campaign unlike any we have ever conducted in our nearly 30-year history, will advance this new grant program, helping to ensure all those facing cancer continue to receive potentially lifesaving therapies.
Read MoreFund One Day
It costs just $19.62 per patient per day in a Gateway-funded cancer clinical trial.
Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniversary, birthday, wedding, bar/bat mitzvah or graduation.
LATEST CANCER RESEARCH
Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.
Trial Type: Pediatric Blood Cancer
Phase I/II Trial of Trivalent CAR T cells in Acute Lymphoblastic Leukemia
Nabil Ahmed, MD, MPH
Baylor College of Medicine
Trial Type: Kidney Cancer
Clinical TrialPhase II Trial of Relatlimab plus Nivolumab in Renal Medullary Carcinoma
Pavlos Msaouel, MD PhD
MD Anderson Cancer Center
